Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Katie A Johnson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA. Hauptthemen laut MEDLINE: Streptococcus thermophilus, CRISPR-Cas Systems, RNA, Viral, Ribonucleases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Type III CRISPR immune systems bind viral or plasmid RNA transcripts and activate Csm3/Cmr4 and Cas10 nucleases to uniquely cleave both invader RNA and DNA, respectively. Additionally, type III effector complexes generate cyclic oligoadenylate (cOA) signaling molecules to activate trans-acting, auxiliary Csm6/Csx1 ribonucleases, previously proposed to be non-specific in their in vivo RNA cleavage preference. Despite extensive in vitro studies, the nuclease requirements of type III systems in their native contexts remain poorly understood. Here we systematically investigated the in vivo roles for immunity of each of the three Streptococcus thermophilus (Sth) type III-A Cas nucleases and cOA signaling by challenging nuclease defective mutant strains with plasmid and phage infections. Our results reveal that RNA cleavage by Csm6 is both sufficient and essential for maintaining wild-type levels of immunity. Importantly, Csm6 RNase activity leads to immunity against even high levels of phage challenge without causing host cell dormancy or death. Transcriptomic analyses during phage infection indicated Csm6-mediated and crRNA-directed preferential cleavage of phage transcripts. Our findings highlight the critical role of Csm6 RNase activity in type III immunity and demonstrate specificity for invader RNA transcripts by Csm6 to ensure host cell survival upon phage infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, USA.
- Department of Genetics and Genome Sciences, Institute for Systems Genomics, UConn Health, Farmington, CT, USA.
- Department of Microbiology, University of Georgia, Athens, GA, USA.
- Department of Genetics, University of Georgia, Athens, GA, USA.
ORCID-Profile: Michael P Terns
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Johnson, K. A., Garrett, S. C., Noble-Molnar, C., Elgarhi, H. A., Woodside, W. T., Cooper, C., Zhang, X., Olson, S., Catchpole, R. J., Graveley, B. R., & Terns, M. P. (2024). Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae856
Vancouver
Johnson KA, Garrett SC, Noble-Molnar C, Elgarhi HA, Woodside WT, Cooper C, et al. Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae856
BibTeX
@article{Johnson2024,
author = {Johnson, Katie A and Garrett, Sandra C and Noble-Molnar, Christopher and Elgarhi, Hanna A and Woodside, Walter T and Cooper, Clare and Zhang, Xinfu and Olson, Sara and Catchpole, Ryan J and Graveley, Brenton R and Terns, Michael P},
title = {Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae856}
}
EUVIMED